Skip to main content
SpringerLink
Log in

Nuclear Medicine Procedures

  • Chapter
  • First Online:
Nuclear Medicine

  • 2198 Accesses

Abstract

The thyroid gland is a butterfly-shaped organ situated on the anterior side of the neck. The primary function of the thyroid is the production of the hormones triiodothyronine (T3), thyroxine (T4), and calcitonin. It makes and stores essential hormones that help regulate the heart rate, blood pressure, body temperature, and rate of metabolism in the body. It also helps to control the levels of calcium and phosphorus in the blood which are needed to keep the bones strong and healthy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Balon HR, Silberstein EB, Meier DA, Charkes ND, et al. Society of Nuclear Medicine Procedure Guideline for Thyroid Uptake Measurement, Version 3.0, approved Sept 5, 2006.

    Google Scholar 

  2. Balon HR, Silberstein EB, Meier DA, Charkes ND, et al. Society of Nuclear Medicine Procedure Guideline for Thyroid Scintigraphy, Version 3.0, Approved Sept 10, 2006.

    Google Scholar 

  3. IAEA Training Material on Radiation Protection in Nuclear Medicine, Part 6. Medical Exposure Protection of the Patients, Module 6.7. Examination of children, pregnant women and lactating women, Slide no. 116–7.

    Google Scholar 

  4. Selby JB, Buse MG, Gooneratne NS, Moore DO. The Anger camera and the pertechnetate ion in the routine evaluation of thyroid uptake and imaging. Clin Nucl Med. 1979;4:233–7.

    Article  CAS  PubMed  Google Scholar 

  5. Bombardieri E, Giammarile F, Aktolun C, Baum RP, et al. EANM procedures guidelines for tumour imaging with 131I/123I-metaiodobenzylguanidine (mIBG).

    Google Scholar 

  6. Ell PJ, Gambhir SS. Nuclear medicine in clinical diagnosis and treatment. 3rd ed. 2004. p. 165–74. ISBN 0443073120. Reprinted in 2005.

    Google Scholar 

  7. Verga V, Muratori F, Sacco G, Ban F, Libroia A. Role of 131iodine MIBG and 99mTc(V) DMSA in the diagnostic value of MTC. Henry Ford Hosp Med J. 1989;37:175–7.

    CAS  PubMed  Google Scholar 

  8. Clarke SEM, Fogelman I, Lazarus CR, Edwards S, Maisey MN. A Comparison of 131I-MIBG and 99mTc-pentavalent-DMSA for imaging patients with medullary carcinoma of the thyroid. In: Schmidt HAE, Emrich D, editors. Nuclearmedizin-Nuclear medicine in research and practice. Stuttgart: Schattauer; 1987. p. 375–8.

    Google Scholar 

  9. Guerra UP, Pizzocara C, Terzi A. New tracers for imaging MTC. Nucl Med Comm. 1989;10:285–95.

    Article  CAS  Google Scholar 

  10. Chaudhary AR, Lewis MK, Bingham JB, Clarke SEM. Registration of MR and SPECT images in medullary thyroid carcinoma. Nucl Med Comm. 1993;14:256.

    Article  Google Scholar 

  11. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 97–9. ISBN 978-0-323-02946-9.

    Google Scholar 

  12. Patterson NR, Jake G. Graves’ disease. In: Our own words. Blue Note Pubns. 2002. ISBN 1-878398-20-2.

    Google Scholar 

  13. Francis DL, Katzka DA. Achalasia: update on the disease and its treatment. Gastroenterology. 2010;139(2):369–74.

    Article  PubMed  Google Scholar 

  14. Greenspan BS, Dillehay G, Intenzo C, Lavely WC, et al. SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol. 2012;40(2):111–8.

    Article  PubMed  Google Scholar 

  15. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 152–3. ISBN 978-0-323-02946-9.

    Google Scholar 

  16. Tulchinsky M, Ciak BW, Delbeke D, Hilson A, Holes-Lewis KA, Stabin MG, Ziessman HA. SNM practice guideline for hepatobiliary scintigraphy 4.0*. J Nucl Med Technol. 2010;38(4):210–8.

    Article  PubMed  Google Scholar 

  17. Sostre S, Kalloo AN, Spiegler EJ, Camargo EE, Wagner Jr HN. A noninvasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score. J Nucl Med. 1992;33:1216–22.

    CAS  PubMed  Google Scholar 

  18. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites in radiology. 3rd ed. ISBN 978-0-323-02946-9. p. 190.

    Google Scholar 

  19. ACR–SNM–SPR practice guideline for the performance of liver and spleen scintigraphy Revised 2010 (Res. 27)*.

    Google Scholar 

  20. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 214. ISBN 978-0-323-02946-9.

    Google Scholar 

  21. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 216. ISBN 978-0-323-02946-9.

    Google Scholar 

  22. Shulkin BL, Mandell GA, Cooper JA, Leonard JC, Majd M, Parisi MT, Sfakianakis GN, Balon HR, Donohoe KJ. Procedure guideline for diuretic 21. Renography in children 3.0*. J Nucl Med Technol. 2008;36(3):162–8. doi:10.2967/jnmt.108.056622. Approved by Board of Directors of the SNM on Apr 15, 2007.

    Article  PubMed  Google Scholar 

  23. Ell PJ, Gambhir SS. Nuclear medicine in clinical diagnosis and treatment. 3rd ed. UK: Churchill Livingstone London; 2004.

    Google Scholar 

  24. Mandell GA, Eggli DF, Gilday DL, Heyman S, et al. Society of Nuclear Medicine Procedure Guideline for Renal Cortical Scintigraphy in Children version 3.0, Approved June 20, 2003. p. 195–8.

    Google Scholar 

  25. Taylor AT Jr., Blaufox MT, Dubovsky EV, Fine EJ, et al. Society of Nuclear Medicine Procedure Guideline for Diagnosis of Renovascular Hypertension version 3.0, approved June 20, 2003. p. 99–104.

    Google Scholar 

  26. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 233. ISBN 978-0-323-02946-9.

    Google Scholar 

  27. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 239–46. ISBN 978-0-323-02946-9.

    Google Scholar 

  28. American College of Radiology practice guideline for the performance of scrotal scintigraphy, Revised 2004 (Res. 31f) Effective 10/1/04. p. 545–7.

    Google Scholar 

  29. Strauss HW, Miller DD, Wittry MD, Cerqueira MD, Garcia EV, et al. Procedure guideline for myocardial perfusion imaging 3.3*approved by the Board of Directors of the SNM on June 14, 2008. p. 155–61.

    Google Scholar 

  30. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 463. ISBN 978-0-323-02946-9.

    Google Scholar 

  31. Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005;32:855–97. doi:10.1007/s00259-005-1779-y.

    Article  CAS  PubMed  Google Scholar 

  32. Atenolol accessed from the website https://en.wikipedia.org/wiki/Atenolol on 17 Mar 14.

  33. Carvedilol accessed from the website https://en.wikipedia.org/wiki/Carvedilol on 17 Mar 14.

  34. Metaprolol accessed from the website https://en.wikipedia.org/wiki/Metaprolol on 17 Mar 14.

  35. Timolol accessed from the website https://en.wikipedia.org/wiki/Timolol on 17 Mar 14.

  36. Amlodipine accessed from the website https://en.wikipedia.org/wiki/Amlodipine on 17 Mar 14.

  37. Nifedipine accessed from the website https://en.wikipedia.org/wiki/Nifedipine on 17 Mar 14.

  38. Glyceryl Trinitrate accessed from the website https://en.wikipedia.org/wiki/GlycerylTrinitrate on 17 Mar 14.

  39. Scheiner J, Wittry MD, Royal HD, Machac J, et al. Society of Nuclear Medicine Procedure Guideline for Gated Equilibrium Radionuclide Ventriculography version 3.0, approved June 15, 2002. Society of Nuclear Medicine, USA. Published in Jun 2002.

    Google Scholar 

  40. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 347–8. ISBN 978-0-323-02946-9.

    Google Scholar 

  41. ACR–SNM–SPR practice guideline for the performance of gastrointestinal scintigraphy Revised 2010 (Res. 29).

    Google Scholar 

  42. Donohoe KJ, Maurer AH, Ziessman HA, Urbain JC, Royal HD, Martin-Comin J. Procedure guideline for adult solid-meal gastric-emptying study 3.0* approved by the Board of Directors of the SNM on Feb 8, 2009.

    Google Scholar 

  43. Wikipedia, the free encyclopedia/gastrointestinal bleeding.

    Google Scholar 

  44. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 365. ISBN 978-0-323-02946-9.

    Google Scholar 

  45. Martin JP, Connor PD, Charles K. Meckel’s diverticulum. Am Fam Physician. 2000;61(4):1037–42.

    CAS  PubMed  Google Scholar 

  46. Mattei P. Fundamentals of pediatric surgery. New York: Springer Science + Business Media, LLC.; 2011.

    Book  Google Scholar 

  47. Juni JE, Waxman AD, Devous MD, Tikofsky RS, Ichise M, Van Heertum RL, Carretta RF, Chen CC. Procedure guideline for brain perfusion SPECT using 99mTc radiopharmaceuticals 3.0*, approved by the Board of Directors of the SNM on Feb 8, 2009.

    Google Scholar 

  48. What is SPECT Imaging? With sub title Healthy Surface & Healthy Active at website http://www.brainplace.com/.

  49. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 444. ISBN 978-0-323-02946-9.

    Google Scholar 

  50. Summary of Product Characteristics for Indium (111In) DTPA, solution for injection, Mallinckrodt Medical, Solution for injections. p. 3.

    Google Scholar 

  51. Parker JA, Coleman RE, Grady E, Royal HD, Siegel BA, Stabin MG, Sostman HD, Hilson AJW. SNM practice guideline for lung scintigraphy 4.0*approved by the Board of Directors of the SNM on July 19, 2011. Published in 2012 by the Society of Nuclear Medicine, Inc. doi: 10.2967/jnmt.111.101386.

  52. Dacrocystography accessed from the website https://en.wikipedia.org/wiki/Dacrocystography#dacrocystography on 17 Mar 14.

  53. Ell PJ, Gambhir SS. Nuclear medicine in clinical diagnosis and treatment. vol 3. ISBN 0-443-07312-0. p. 783–8.

    Google Scholar 

  54. Palestro CJ, Brown ML, Forstrom LA, Greenspan BS, McAfee JG, Royal HD, Schauwecker DS, Seabold JE, Signore A. Society of Nuclear Medicine Procedure Guideline for Gallium Scintigraphy in Inflammation Version 3.0, approved June 2, 2004.

    Google Scholar 

  55. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 386. ISBN 978-0-323-02946-9.

    Google Scholar 

  56. ACR–SNM–SPR practice guideline for the performance of scintigraphy for inflammation and infection, Revised 2009 (Res. 15)*.

    Google Scholar 

  57. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 264–6. ISBN 978-0-323-02946-9.

    Google Scholar 

  58. Khalkhali I, Caravaglia G, Abdel-Nabi HH, Peller PJ, Taillefer R, Vande Streek PR, Van de Wiele C. Society of Nuclear Medicine Procedure Guideline for Breast Scintigraphy Version 2.0, approved June 2, 2004.

    Google Scholar 

  59. Information leaflet 99Tc-Tektrotyd, Institute of Atomic Energy, Polatom, Poland.

    Google Scholar 

  60. Goldsmith SJ, Parsons W, Guiberteau MJ, Stern LH, Lanzkowsky L, Weigert J, Heston TF, Jones E, Buscombe J, Stabin MG. SNM practice guideline for breast ccintigraphy with breast-specific g-Cameras 1.0*approved by the Board of Directors of the SNM on June 4, 2010.

    Google Scholar 

  61. Ziessman HA, O’Malley JP, Thrall JH. Nuclear medicine: the requisites. 3rd ed. Philadelphia: Mosby; 2006. p. 280. ISBN 978-0-323-02946-9.

    Google Scholar 

  62. Imaging techniques for the diagnosis of ovarian cancers: immunoscintigraphy. 21 Dec 2004.

    Google Scholar 

  63. Glossary of Molecular Imaging Terms, Society of Nuclear Medicine and Molecular imaging. http://interactive.snm.org/index.cfm?PageID=10.

  64. Waxman AD, Herholz K, Lewis DH, Herscovitch P, Minoshima S, Ichise M, Drzezga AE, Devous MD, Mountz JM. Society of Nuclear Medicine Procedure Guideline for FDG PET Brain Imaging Version 1.0, approved Feb 8, 2009.

    Google Scholar 

  65. Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36(12):2103–10. doi:10.1007/s00259-009-1264-0. published online 17 Oct 2009.

    Article  PubMed  Google Scholar 

  66. Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005;32(7):855–97. Springer; 2005. Published online: 21 May 2005.

    Google Scholar 

  67. Schinkel AF, Bax JJ, Valkema R, Elhendy A, van Domburg RT, Vourvouri EC, et al. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability. J Nucl Med. 2003;44:877–83.

    PubMed  Google Scholar 

  68. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ, Knuuti J, Schelbert HR, Travin MI. PET myocardial perfusion and metabolism clinical imaging, the American Society of Nuclear Cardiology imaging guidelines for nuclear cardiology procedures. J Nucl Cardiol 2009;16(4). doi:10.1007/s12350-009-9094-9.

  69. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0*, approved by the Board of Directors of the Society of Nuclear Medicine on Feb 11, 2006.

    Google Scholar 

  70. Sodium fluoride F 18 injection investigator’s brochure. National Cancer Institute Cancer Imaging Program Web site. Available at: http://imaging.cancer.gov/images/ Documents/bccff836-d508-4ceb-b22a-894f563cc352/NaF_IB_Edition1_072808.pdf. Released Aug 2008. Accessed 26 Aug 2010.

  71. Segall G, Delbeke D, Stabin MG, Even-Sapir E, Fair J, Sajdak R, Smith GT. SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0*. J Nucl Med. 2010;51(11):1813–20. doi:10.2967/jnumed.110.082263. Approved by the Board of Directors of the SNM on June 4, 2010.

    Article  PubMed  Google Scholar 

  72. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69:1–19.

    Article  CAS  PubMed  Google Scholar 

  73. Lisa B, Marnix L, Carlo C, Glenn F, Boudewijn B, Arturo C, Francesco G. EANM procedure guideline for treatment of refractory metastatic bone pain. Eur J Nucl Med Mol Imaging. 2008;35(10):1934–40. doi:10.1007/s00259-008-0841-y. Last amended Mar 2008.

    Article  Google Scholar 

  74. Silberstein EB, Buscombe JR, McEwan A, Taylo AT. Society of Nuclear Medicine Procedure Guideline for Palliative Treatment of Painful Bone Metastases, version 3.0, approved Jan 25, 2003. p. 147–53.

    Google Scholar 

  75. Silberstein EB, Alavi A, Balon HR, Becker DV, et al. Society of Nuclear Medicine Procedure Guideline for Therapy of Thyroid Disease with Iodine-131 (Sodium Iodide) Version 2.0.

    Google Scholar 

  76. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJG, Tennvall J, Bombardier E. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008;35(10):1941–59. doi:10.1007/s00259-008-0883-1. EANM.

    Article  CAS  PubMed  Google Scholar 

  77. Stokkel MPM, Handkiewicz Junak D, Lassmann M, Dietlein M, Luste M. EANM procedure guidelines for therapy of benign thyroid disease. Eur J Nucl Med Mol Imaging. 2010;37:2218–28. doi:10.1007/s00259-010-1536-8. Published online: 13 July 2010, Springer 2010.

    Article  PubMed  Google Scholar 

  78. Iodine-131 accessed from the website https://en.wikipedia.org/wiki/Iodine-131 on 17 Mar 14.

  79. Giammarile F, Chiti A, Lassmann M, Brans B, Flux G. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy. Eur J Nucl Med Mol Imaging. 2008;35:1039–47. doi:10.1007/s00259-008-0715-3. Published online: 15 Feb 2008.

    Article  CAS  PubMed  Google Scholar 

  80. Weiland DM, Wu J, Brown LE, Manger TJ, Swanson DP, Beierwaltes WH. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with 131I meta-iodobenzylguanidine. J Nucl Med. 1980;21:349–53.

    Google Scholar 

  81. Beierwaltes WH. Treatment of neuroblastoma with 131I-MIBG: dosimetric problems and perspectives. Med Pediatr Oncol. 1987;15:188–91.

    Article  CAS  PubMed  Google Scholar 

  82. Giammarile F, Lumbroso J, Ricard M, Aubert B, Hartmann O, et al. Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection. Eur J Nucl Med. 1995;22(10):1180–3.

    Article  CAS  PubMed  Google Scholar 

  83. Hoefnagel CA, Lewington VJ. MIBG therapy. In: Murray IPC, Ell PJ, editors. Nuclear medicine in clinical diagnosis and treatment, vol. 2. 2nd ed. New York: Churchill Livingstone; 1998. p. 1067–81.

    Google Scholar 

  84. Garaventa A, Gambini C, Villavecchia G, et al. Second malignancies in children with neuroblastoma after combined treatment with 131I-MIBG. Cancer. 2003;97(5):1332–8.

    Article  CAS  PubMed  Google Scholar 

  85. EANM procedure guidelines for radiosynovectomy, Guidelines issued by The EANM Radionuclide Therapy Committee on date: Oct 4, 2002.

    Google Scholar 

  86. Jan T, Boudewijn B. EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseases. Eur J Nucl Med Mol Imaging. 2007;34:1324–7. doi:10.1007/s00259-007-0407-4. Published online: 30 Mar 2007.

    Article  Google Scholar 

  87. Jan T, Manfred F, Angelika Bischof D, Emilio B, Lisa B, Francesco G, Michael L, Wim O, Boudewijn B. EANM procedure guideline of radio-immunotherapy for B-cell lymphoma with 90Y-radiolabeled ibritumomab tiuxetan (Zevalin®). Eur J Nucl Med Mol Imaging. 2007;34(4):616–22. Last amended: Oct 2006.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, INHS, Asvini, Mumbai, India

    Dibya Prakash

Authors
  1. Dibya Prakash
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer India

About this chapter

Cite this chapter

Prakash, D. (2014). Nuclear Medicine Procedures. In: Nuclear Medicine. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1826-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-1826-5_4

  • Published:

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-1825-8

  • Online ISBN: 978-81-322-1826-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation